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M. F. Balmer,* and B. A. Schwetz*
Male and female Sprague-Dawley rats were exposed to vinylidene chloride (VDC) orally or by inhala-
tion in 2-year toxicological studies. Interim results are included in this report. VDC was given in the
drinking water at mean + S.D. concentrations of 0, 68 ± 13, 106 ± 22, and 220 ± 35 ppm which
produced mean ± S.D. dosage levels of0, 5.9 ± 0.6, 10.0 ± 1.2, and 19.3 ± 2.7 mg/kg for male rats and
0, 7.5 ± 0.4, 12.6 ± 1.1, and 25.6 + 2.4 mg/kg for female rats. Forty-eight rats/sex/VDC level and 80
rats/sex in the control group were used in the 2-year study with an interim kill of an additional 10
rats/sex/level at 90 days. In the inhalation study, rats were exposed to 0, 10, or 40 ppm of VDC vapor 6
hr/day, S days/week for S weeks, after which the exposure levels were changed to 0, 25, and 75 ppm of
VDC. Exposure continued for a total of 18 months and the rats held for observation an additional 6
months. Interim kills occurred at 1, 6 and 12 months. A separate 90-day study using 20 rats/sex/level was
conducted at 0, 25, and 75 ppm of VDC vapor. There were 86 rats/sex/level in the 2-year portion of the
study. The parameters monitored were: body weight, food and water consumption (drinking water study
only), hematology, clinical chemistries, cytogenetics ofbone marrow cells (inhalation study only), mortal-
ity, terminal organ weights, and gross and histopathology. Based on interim kills and gross pathologic
observations, the main conclusions are: increased cytoplasmic vacuolation ofhepatocytes was seen in the
livers of rats given 200 ppm VDC in drinking water or 25 or 75 ppm VDC vapor by inhalation; based on
gross tumor count, tumor incidence in VDC-exposed rats was not greater than controls.
Introduction
Vinylidene chloride (1,1-dichloroethylene, VDC,
H2C= CC12) is widely used in copolymerization with
other monomers. The polymers containing VDC
are used in many applications including several
where contact with food occurs. Thus potential
human exposure to VDC could occur by ingestion
because of possible residues of unpolymerized
VDC in food packaging materials and by inhalation
of VDC vapor in air in the work atmosphere.
Currently available pertinent toxicological data
on vinylidene chloride are limited. Irish (1) reported
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liver and kidney injury to animals exposed 8 hr/day,
5 days/week by inhalation for several months at
concentrations of 100 and 50 ppm. Minimal injury
was seen to these organs at 25 ppm. Prendergast,
et al. (2) reported no mortality of animals exposed
for 30 days, 8 hr/day, 5 days/week to 100 ppm of
VDC vapor. Mortality was seen in monkeys and
guinea pigs exposed 24 hr/day for 90 days to con-
centrations of47 and 25 ppm and 47, 25 and 15 ppm
of VDC vapor respectively. Liver injury was re-
ported in dogs, monkeys and rats and kidney
changes in rats continuously exposed for 90 days to
45 ppm. Gage (3) reported that 20 exposures of rats
for 6 hr daily to 500 ppm vinylidene chloride pro-
duced nasal irritation, decreased body weight gain
and liver cell degeneration. Siegel et al. (4) re-
December 1977 33ported that the single-exposure LC50 for rats was
6350 ppm. No studies ofchronic oral administration
of VDC itself have been reported.
Because of the lack of toxicological information
available on VDC, additional toxicological studies
of VDC in animals were deemed necessary to
elucidate more fully the action of VDC after
chronic exposures. The studies discussed in this re-
port are a part of the toxicologic investigations on
VDC conducted in the Toxicology Research
Laboratory of Dow Chemical, U.S.A. under the
sponsorship of a number of VDC manufacturers
and users through the Manufacturing Chemists As-
sociation.
Studies by two routes of exposure, ingestion via
inclusion in drinking water and inhalation, were un-
dertaken in rats. The objectives of the two studies
were to evaluate toxicity (including carcinogenicity)
of VDC by the oral and inhalation routes in rats.
Interim results of these studies are reported here-
interim in that not all histopathology had been com-
pleted at the time of the conference at which this
information was presented. Complete results will
be published at a later date.
Materials
The composition of typical samples used in the
vinylidene chloride (VDC) two-year drinking water
and inhalation studies are listed in Tables 1 and 2,
respectively. The samples were analyzed by gas
Table 1. Typical sample composition for vinylidene
chloride used in two-year drinking water study in rats.
Concentration,
Impurity ppm
Vinyl bromide 4
Vinyl chloride 3-50
Trans-1,2-dichloroethene 138-1700
Cis-l .2-dichloroethene 24-680
1,I,I-Trichloroethane 2-60
1,1,2-Trichoroethane 48
Hydroquinone monomethyl ether 2
(inhibitor)
chromatography. Samples used for both studies
were supplied by Dow Chemical, U.S.A. The sam-
ples for the two studies were essentially the same
except the material used in the inhalation study had
a higher level of the inhibitor, hydroquinone
monomethyl ether. Since the method used to gener-
ate VDC vapor for the inhalation studies evapo-
rated the sample completely, the maximum con-
centrations for the various impurities that could
occur are shown in Table 2. These represent max-
imum values calculated from the highest level of
impurity found in the liquid VDC samples. The
concentrations of all of the structurally related im-
purities were low. It is unlikely that any of them
contributed significantly to any toxicity seen in the
studies.
Methods
Animals
Animals used in both studies were Sprague-
Dawley SPF (specific pathogen-free) derived rats
purchased from Spartan Laboratories, Haslett,
Michigan. The rats were 6-7 weeks old when
purchased.
Design of Two-Year Drinking Water Study
This study consisted of three components: the
two-year portion, with which this report is mainly
concerned; a 90-day study in which the rats were
treated simultaneously with those in the two-year
study; and a three-generation reproduction study.
In the latter portion, the parents for the Fo, or the
primary generation, were taken from animals in the
two-year study, used to produce the next genera-
tion and then returned to the two-year study. The
Fo parent rats were given drinking water containing
VDC at all times. Results ofthe reproduction study
are not included in this report. A total of66 rats per
sex per VDC dosage level and 98 rats per sex in the
control group were used. There were 48 rats per sex
in each of the three VDC dosage levels and 80 rats
Table 2. Typical sample composition of vinylidene chloride and calculated chamber
concentrations of impurities in two-year inhalation study in rats.
Concentration Maximum concentration
in liquid (calculated) in 75
Impurity sample, ppm ppm atmosphere, ppb
Vinyl chloride 2-6a 113
Vinyl bromide 0-14 1.1
Cis-1,2-dichloroethene 30-1600 126
Trans-1,2-dichloroethene 100-3000 237
1,1,1-Trichloroethane 0-8 0.5
1,1,2-Trichloroethane 0-0.9 0.05
Hydroquinone monomethyl ether 130-400 121
(inhibitor)
aOne sample contained 1300 ppm of vinyl chloride.
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Ten rats per sex per dosage level (including the con-
trol group) were used in the 90-day study. Two rats
per sex per group were sacrificed at 1, 3, 10, and 30
days of the study for determination of nonprotein
sulfhydryl levels in liver and kidney.
The nominal concentrations ofVDC in the drink-
ing water (tap water was used) were 0, 60, 100, or
200 ppm (w/v). The actual mean ± SD VDC con-
centrations, determined by gas chromatographic
analysis, were 0, 68 ± 13, 106 ± 22, and 220 ± 35
ppm. The mean ± SD daily dosage levels in mg/kg
based on the amount of water consumed, were 0,
5.9 ± 0.6, 10.0 ± 1.2, and 19.3 ± 2.7 mg/kg for male
rats and 0, 7.5 ± 0.4, 12.6 ± 1.1 and 25.6 ± 2.4
mg/kg for female rats. Drinking water containing
VDC was the only source of water throughout the
study.
The rats were observed at regular intervals for
signs of toxicity. Ground commercial chow and
water (containing the appropriate concentration of
VDC) were freely available at all times. Food and
water consumption were measured throughout the
study. Body weights were recorded weekly at first
and then monthly throughout the remainder of the
study.
Hematologic and clinical chemical measurements
and urinalyses were carried out at 30 and 90 days of
the 90-day study and at months 6, 12, 18, and 24 of
the two-year study. Determinations of nonprotein
sulfhydryl levels in liver and kidney (5) were carried
out on rats killed on days 1, 3, 10, 30, and 90 of the
90-day study and at the end of the two-year study.
Hematologic measurements included total erythro-
cyte count, total and differential leukocyte count,
packed cell volume and hemoglobin concentration.
Urinalysis included determination of specific grav-
ity, pH, glucose, ketones, bilirubin, occult blood,
and protein. Clinical chemical measurements in-
cluded determination ofserum alkaline phosphatase
(AP) activity, serum glutamic pyruvic transaminase
(SGPT) activity, and levels of urea nitrogen in the
blood (BUN).
All rats were subjected to a complete gross
pathologic examination by a veterinary pathologist
whether killed at a scheduled sacrifice, killed in a
moribund state, or after having died spontaneously.
Weights ofbrain, heart, liver, kidney, and testes of
rats killed at times of scheduled sacrifice were re-
corded. Organs and tissues from all rats were pre-
served in formalin for histopathologic examination.
Special attention was given to grossly observed
tumors or tumorlike processes in rats in the two-
year study, and all such lesions were included in the
tissues saved for histopathologic evaluation.
Statistical evaluation of hematology, clinical
chemistry, organ weight and body weight data were
evaluated using an analysis of variance and
Dunnett's test (6). When histopathology is com-
plete, tumor incidence will be evaluated by the
Fisher exact probability test (7). The level of sig-
nificance chosen for all cases is p < 0.05.
Design of Two-Year Repeated
Inhalation Study
In this study, 104 male and 104 female rats were
used in each of three groups: the control group and
two groups exposed to VDC vapor. Exposures
were 6 hr/day, 5 days/week for 18 months. For the
first 5 weeks of exposure, the exposure levels were
10 or 40 ppm (40 or 159 mg/m3) of VDC. At the end
of 4 weeks of exposure there was an interim kill of
four animals per sex per level. As no effects were
found at that interim kill, exposure levels were
raised to 25 or 75 ppm (99 or 298 mg/m3) at the end
of5 weeks, one week after the kill. At 6 months into
the study, 1 month ofexposure to 10 or 40 ppm and
5 months of exposure to 25 or 75 ppm of VDC, an
additional five animals per sex per level were killed.
After the 30-day sacrifice, four rats per sex per level
had been added to the groups specifically for
cytogenetic evaluation. At the end of six months of
exposure of these animals to 25 or 75 ppm of VDC
(seven months into the study), these rats were killed
and bone marrow cells collected for cytogenetic
evaluation. After 12 months of exposure five rats
per sex per level were sacrificed. The group size per
sex for the two year portion of the study, after sub-
tracting for interim kills, was 86. Exposure was dis-
continued at 18 months, and all animals still alive
were maintained until 24 months, at which time all
rats remaining alive were killed.
An additional 20 rats per sex per level were ex-
posed at 0, 25 or 75 ppm VDC in a separate 90-day
study. In this study eight rats per sex per level were
killed after 30 days and the remaining 12 per sex per
level at 90 days.
Exposures were carried out in 3.7 m3 stainless
steel chambers under dynamic air flow conditions.
Control rats were maintained under ambient condi-
tions in an animal holding room. Commercial pel-
leted chow and water were freely available at all
times except during exposure, when food and water
were removed from all groups, including controls.
The VDC vapor concentration was generated by
metering liquid VDC into a temperature controlled
vaporization flask. The vapor was swept by air into
the exposure chamber. Chamber concentrations of
VDC were monitored by infrared spectro-
photometry. The nominal and mean analytical con-
centrations are shown in Table 3. Also shown is the
December 1977 35percent of exposure days on which the analytical
concentration was within 25% of nominal concen-
tration. The range of analytically determined con-
centrations recorded is shown in the last line of
Table 3, demonstrating that there was no overlap of
concentrations between levels.
Gross and histopathologic evaluation of all ani-
mals and terminal organ weights at the interim and
final sacrifices were carried out on rats in the inha-
lation study in the same manner as described for the
drinking water study. Statistical evaluation of data
was also the same as described for the drinking
water study.
Table 3. Chamber concentrations of vinylidene chloride vapor in inhalation studies.
First 35 days of Balance of
2-yr study 2-yr study 90-day study
Nominal concentration, ppm 10 40 25 75 25 75
Nominal concentration, mg/m3 40 159 99 298 99 298
Mean analytical concentra-
tion + S D , ppm 9.5+2.5 35.8+6.2 25.4+4.6 72.6±7.5 26.4+4.8 72.7+9.8
Exposure days within 25%
of nominal concen-
tration, % 68 86 81 96 82 98
Range ofconcentration, ppm 5.0-13.7 20.0-45.1 12.0-39.5 52.1-96.0
The rats were observed frequently for signs of
toxicity. Food and water consumption were not
measured in the inhalation studies. Body weights
were recorded weekly at first and then once per
month.
Hematologic measurements including the same
parameters as in the drinking water study, were
made at the 30 and 90 day sacrifices of the 90-day
study and at the 6, 12, and 24 month sacrifices ofthe
two-year study. Clinical chemistry determinations
of SGPT and AP activity and BUN levels were
made at the time ofeach interim kill. Blood glucose
levels were carried out at the 12 and 24 month kills
only. Additional determinations of SGPT activity
were made at 2 and 7 weeks ofthe two-year study.
Results and Discussion
Drinking Water Study
Mean body weights of rats included in the two
year drinking water study of VDC are shown
graphically in Figure 1. There were occasional
statistically significant differences between one or
more exposure groups and controls, but there were
no consistent overall differences in mean body
weight between VDC-exposed and control groups.
There were sporadic statistically significant dif-
ferences between VDC-treated and control rats in
food and water consumption and in clinical chemis-
try, hematology, and urinalysis determinations.
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FIGURE 1. Mean body weight of male and female rats given vinylidene chloride in their drinking water for two years.
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36These differences did not occur in a dose-related
fashion; they were not seen consistently from one
determination to another and were not considered
to be related to treatment with VDC. The determi-
nation of nonprotein sulihydryl levels in liver and
kidney showed no differences between VDC-
treated and control rats.
Cumulative percent mortality for male rats in the
two-year drinking water study is graphed in Figure
2. All three treatment groups exhibited slightly
higher mortality than the control group. The differ-
ences between the treatment groups and the control
values were not dose-related except that there were
a few more deaths in the 200 ppm group early in the
study.
For female rats (Fig. 3), the two lower level
treatment groups had lower mortality than the con-
trol group. The 200 ppm VDC-treatment group had
higher mortality than the control group during part
of the second year of the study, but not at the ter-
mination of the study. Overall, the difference in
mortality for male or female rats given VDC were
too small to be of toxicological significance.
Except for a decreased kidney to body weight
ratio in male rats at the lowest VDC level compared
to controls at the 90-day sacrifice, there were no
statistically significant differences in organ weights
or organ to body weight ratios at either the 90-day
or two-year sacrifice.
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With respect to nontumor pathology, the only
treatment related effect seen was increased cyto-
plasmic vacuolation ofhepatocytes in both sexes of
rats given 200 ppm of VDC in their drinking water.
This was a minimal change which wasjudged to be
reversible if the animals had been removed from
treatment. The liver effect described was seen in
rats sacrificed after 90 days of treatment. At the
time of this interim report, histopathology had not
been completed on animals which died spontane-
ously or were killed after two years of treatment to
verify whether the liver effect continues to be seen
at later stages of the study.
Data on tumor pathology are shown in Table 4.
These data are based on gross pathologic observa-
tions only. As in other long-term studies in rats,
many kinds ofspontaneous tumors were seen in the
control population. Rather than list all ofthese, the
types of tumors most pertinent to a VDC study
have been included. No tumor categories have been
omitted for which incidence in the VDC-treated
rats is significantly higher than in control rats.
Data for male rats are listed first in Table 4. The
incidence of subcutaneous tumors in the mammary
and midcervical region in the VDC-treated rats was
slightly higher than in the control rats but was not
outside the range which has been experienced with
control rats ofthe same strain in other studies in our
laboratory. Thus, the slightly higher incidence is
16 18 20 22 24
FIGURE 2. Cumulative percent mortality for male rats given vinylidene chloride in their drinking water for two years.
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FIGURE 3. Cumulative percent mortality for female rats given vinylidene chloride in their drinking water for two years.
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not indicative of a treatment related effect. Sub-
cutaneous tumors in the eye, ear, and head region
are the next category indicated. If tumors of Zym-
bal gland were grossly visible at necropsy, they
would be recorded here. Tumors of the Zymbal
gland in rats have been reported by Maltoni (8) to
result from exposure to vinyl chloride. However,
the incidence of subcutaneous tumors in this region
as well as the body or limb region is clearly not
significantly higher in VDC-treated rats than in the
control group of the present study. Nodular prolif-
eration in the liver as a primary site did not occur at
higher incidence in VDC-treated rats than in con-
trol rats. The incidence of other types of tumors in
the liver were also so low as to be of no toxicologi-
cal concern. In the kidney, an organ which Maltoni
had verbally reported to be affected in mice by
VDC, a primary site tumor was seen in two control
rats and only one VDC-treated rat, and that at the
lowest dose level.
In female Sprague-Dawley rats, mammary
tumors, classified here as tumors in the mammary
and midcervical region, occurred spontaneously at
very high incidence as illustrated by the incidence
in the control group. In this case, the percentage
incidence of mammary tumors was higher in VDC-
treated rats than in control rats, but the incidence in
control animals was so high that the slightly higher
incidence in VDC-treated rats is not statistically or
toxicologically significant. Subcutaneous tumors in
the eye, ear, and head region, site ofZymbal gland
tumors ifthey were to be found, occurred with simi-
lar incidence among the groups. A subcutaneous
tumor in the body or limb region occurred in only
one rat, not a meaningful incidence. Nodular prolif-
eration in the liver as a primary site occurred in the
high and low treatment groups at somewhat higher
incidence than in the control group but not at high
enough incidence to be of toxicological signifi-
cance. The other types of liver tumors occurred
only in the control rats. In the kidney, only two
tumors were found as primary site tumors, one in a
VDC-treated rat and one in a control rat.
Repeated Inhalation Study
No clinical signs oftoxicity were seen at any time
in rats in the inhalation study. Mean body weights
of rats in the two-year repeated inhalation study are
shown graphically in Figure 4. Male rats exposed to
VDC vapor gained weight at a slightly lower rate
than control rats during most of the study. The
mean body weights for male rats were statistically
significantly lower for both exposure groups only
during the period of8-12 or 13 months ofthe study.
At other times the mean body weights of VDC-
exposed male rats were not significantly lower than
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Dose, No. animals No. animals Tumors,
Sex Tumor ppm with tumor`' in group %
Control 6/6 80 7.5
M Subcutaneous tumor 200 6/4 47' 8.5
(mammary and mid- 100 6/6 48 12.5
cervical region) 60 6/6 48 12.5
M Subcutaneous tumor Control 4 80 5.0
(eye, ear, and head 200 2 47 4.3
region) 100 0 48 0
60 1 48 2.1
M Subcutaneous tumor Control 2 80 2.5
(body or limb region) 200 0 47 0
100 0 48 0
60 2 48 4.2
M Nodular proliferation Control 5 80 6.3
in liver (primary 200 0 47 0
site) 100 1 48 2.1
60 1 48 2.1
M Liver (metastatic Control 0 80 0
foci) 200 0 47 0
100 0 48 0
60 1 48 2.1
M Liver (diffuse tumor Control 0 80 0
infiltrate and 200 0 47 0
enlarged, associated 100 1 48 2.1
with lymphoid) 60 2 48 4.2
M Kidney (primary site) Control 2 80 2.5
200 0 47 0
100 0 48 0
60 1 48 2.1
F Subcutaneous tumor Control 104/59 80 73.7
(mammary and mid- 200 64/36 48 75.0
cervical region) 100 68/27 48 77.1
60 71/40 48 83.3
F Subcutaneous tumor Control 1 80 1.3
(eye, ear, and head 200 1 48 2.1
region) 100 2 48 4.2
60 1 48 2.1
F Subcutaneous tumor Control 0 80 0
(body or limb region) 200 0 48 0
100 1 48 2.1
60 0 48 0
F Nodular proliferation Control 2 80 2.5
in liver(primary 200 3 48 6.3
site) 100 0 48 0
60 2 48 4.2
F Liver (metastatic Control 1 80 1.3
foci) 200 0 48 0
100 0 48 0
60 0 48 0
F Liver (diffuse tumor Control 2 80 2.5
infiltrate and 200 0 48 0
enlarged, associated 100 0 48 0
with lymphoid) 60 0 48 0
F Kidney (primary site) Control 1 80 1.3
200 0 48 0
100 1 48 2.1
60 0 48 0
aWhere two numbers appear, data representnumber oftumors over number ofanimals with tumors. Percentage is based
on number ofanimals with tumors.
bOne rat was unaccounted for in the 200 ppm group.
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FIGURE 4. Mean body weight of male and female rats exposed to vinylidene chloride vapor in two-year inhalation study.
control rats. The mean body weights of VDC-
exposed female rats were comparable to controls or
slightly higher.
In the hematologic measurements, there were
sporadic statistically significant differences be-
tween VDC-exposed and control rats but no effects
were seen consistently enough to be deemed related
to VDC exposure. There were sporadic differences
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in clinical chemistry values between VDC-exposed
and control rats. None of these differences were
seen consistently at the various kills. There were no
signs of cytogenetic aberrations in the examination
of bone marrow cells collected after 6 months.
Cumulative percent mortality for male rats is
graphed in Figure 5. There was very little difference
in mortality between the various groups, although
16 18 20 22 24
FIGURE 5. Cumulative percent mortality for male rats exposed to vinylidene chloride vapor in two-year inhalation study.
Environmental Health Perspectives 40mortality was slightly higher in the 75 ppm group in
the very last months of the study. For female rats
(Fig. 6), there was slightly increased mortality at
both exposure levels from the 12th month on. In
both sexes, the mortality differences between
groups were small.
In organ weights of animals sacrificed at the in-
terim kills, there was a lower testes to body weight
ratio in male rats exposed to 40 ppm VDC for 30
days than in control rats. There was no associated
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were seen only at the one kill indicated and were
not seen at the times of other interim kills.
In terms of nontumor pathology, the same liver
effect was seen in the rats in the inhalation studies
as was seen at the high level of the drinking water
study. Increased cytoplasmic vacuolation of
hepatocytes was seen at both the 25 and 75 ppm
exposure levels after 30 days ofexposure or longer.
It was not seen in rats exposed to 10 or 40 ppm for
30 days, however.
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FIGURE 6. Cumulative percent mortality for female rats exposed to vinylidene chloride vapor in two-year inhalation study.
pathology in the testes of these animals and this
effect was not seen at any ofthe other interim kills;
therefore it is not attributable to treatment. Lower
liver weights were seen in male rats from both
VDC-exposed groups killed at one year of the
long-term study. The lower liver weights were as-
sociated with lower body weights in these groups,
and there was also a minimal pathologic change in
the liver (see below). The same pathologic change
in the liver was seen in females without decrease in
liver weight. Higher kidney weights were seen in
female rats exposed to both levels of VDC for one
year. There was no associated pathology in this
organ, however. There were no differences in organ
weights between VDC-exposed and control rats at
the kills at 30 and 90 days ofthe 90-day study or at 6
or 24 months of the long-term study. Thus, all the
organ weight changes discussed for each organ
Tumor pathology data are listed in Table 5. Data
are presented for the same types of tumors as for
the drinking water study. These data are tabulated
for the gross observations only. In males, the inci-
dence of subcutaneous tumors of the mammary or
midcervical region was similar in the three groups
and well within the range of historical controls in
our laboratory. The incidence of subcutaneous
tumors of the eye, ear, or head region, the region
where Zymbal gland tumors would be seen, was
very similar among the groups. Subcutaneous
tumors in the body or limb region occurred with a
similar frequency, slightly higher in the treated
animals but not enough to be suggestive of a treat-
ment effect. There were nodules in the liver clas-
sified as a tumor or mass in one control rat and two
rats at the 75 ppm level, not a significant difference
in frequency. Primary tumors in the kidney ofmale
December 1977
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41Table 5. Grossly observed tumors in rats exposed to vinylidene chloride vapor in two-year inhalation study.
Exposure
Level No. animals No. animals
Sex Tumors (ppm) with tumoe in group Tumors, %
Subcutaneous tumor
(mammary or midcervi-
cal region)
Subcutaneous tumor
(eye, ear, or head
region)
Subcutaneous tumor
(body or limb region)
Liver nodule (tumor
or mass)
Kidney (primary site)
Subcutaneous tumor
(mammary or midcervi-
cal region)
Subcutaneous tumor
(eye, ear, or head
region)
Subcutaneous tumor
(body or limb region)
Liver nodule (tumor
or mass)
Kidney (primary site)
Control
75
25
Control
75
25
Control
75
25
Control
75
25
Control
75
25
Control
75
25
Control
75
25
Control
75
25
Control
75
25
Control
75
25
8/6
9/8
8/7
2
2
S
1
4
3
2
0
3
0
0
138/68
159/74
149/73
1
0
2
1
2
2
0
86
85b
86
86
85
86
86
85
86
86
85
86
86
85
86
86
84c
88
86
84
88
86
84
88
86
84
88
86
84
88
7.0
9.4
8.1
2.3
2.4
5.8
1.2
4.7
3.5
1.2
2.4
0
3.5
0
0
79.1
88.1
82.9
1.2
1.2
0
2.3
1.2
2.3
2.3
1.2
0
1.2
1.2
1.1
aWhere two numbers appear, data represent number oftumors over number ofanimals with tumors. Percentage is based
on number of animals with tumors.
bOne male rat was unaccounted for in the 75 ppm exposure group.
cTwo female rats from the 75 ppm exposure group were mistakenly caged with 25 ppm rats.
rats were seen in three controls but in none of the
VDC-exposed animals.
In female rats, as seen in data from the drinking
water study, the incidence of mammary tumors was
very high. Although the incidence in the VDC-
exposed rats was slightly higher than in control rats,
it was not of significance in the face of the high
background incidence. Only two subcutaneous
tumors in the eye, ear or head region were seen, one
in the control group and one in the 75 ppm exposure
group. The number of subcutaneous tumors of the
body or limb region in the various groups was quite
comparable. Liver nodules classified as a tumor or
mass were found in only two control rats and one
rat at the 75 ppm level. In the kidney, there was one
kidney tumor recognized grossly in each of the
groups of the experiment.
Conclusions
The primary conclusions from the vinylidene
chloride toxicity studies for which interim results
are reported here are: (1) the exposure of rats to
VDC in drinking water or by inhalation resulted in
minimal liver changes at 200 ppm in the drinking
water study and at both 75 and 25 ppm in the inhala-
tion study; and (2) based on gross tumor count,
these studies did not reveal increased numbers of
tumors in rats exposed to VDC.
Environmental Health Perspectives
M
M
M
M
M
F
F
F
F
F
42REFERENCES
1. Irish, D. D. In: Industrial Hygiene and Toxicology, F. A.
Patty, Ed. Vol. 11. Toxicology, D. W. Fassett and D. D.
Irish, Eds. Interscience Publishers, New York, 2nd ed.
1963, pp. 1305-1307.
2. Prendergast, J. A., et al. Effects on experimental animals of
long term inhalation of trichloroethylene, carbon tetra-
chloride, 1,1,1-trichloroethane, dichloroethylene. Toxicol.
Appl. Pharmacol. 10: 270 (1967).
3. Gage, J. C. Subacute inhalation toxicity of 109 industrial
chemicals. Brit. J. Ind. Med. 27: 1 (1970).
4. Siegel, J., et al. Effects on experimental animals of acute,
repeated, and continuous inhalation exposure to dichlo-
roacetylene mixtures. Toxicol. Appl. Pharmacol. 18: 168
(1971).
5. Sedlak, J., and Lindsay, R. M. Estimation of total protein-
bound and non-protein sulfhydryl groups in tissue with
Ellman's Reagent. Anal. Biochem. 25: 192 (1968).
6. Steel, R. G. D., and Torrie, H. H. Principles and Pro-
cedures of Statistics. McGraw-Hill, New York, 1960,
pp. 101-105, 111-112.
7. Siegel, S. Non-Parametric Statistics for the Behavioral Sci-
ences. McGraw-Hill, New York, 1956.
8. Maltoni, C., and Lefemine, G. Carcinogenicity bioassays of
vinyl chloride: current results. Ann. N.Y. Acad. Sci., 246:
195 (1975).
December 1977 43